Nahid R. Bhadelia, MD, MA

Associate Professor, Medicine

Nahid Bhadelia
617.358.9192

Biography

Dr. Bhadelia is a board-certified infectious diseases physician and an internationally recognized leader in highly communicable and emerging infectious diseases (EIDs) with clinical, field, academic, and policy experience in pandemic preparedness. She is the Founding Director of BU’s Center for Emerging Infectious Diseases Policy and Research (CEID). In addition to her role at CEID, she is the associate director of the National Emerging Infectious Diseases Laboratories (NEIDL), a state-of-the-art maximum containment research facility at BU.

Over the last decade, Dr. Bhadelia designed and served as the medical director of the Special Pathogens Unit (SPU), a medical unit designed to care for patients with highly communicable diseases, and a state designated Ebola Treatment Center. She has prior and ongoing experience in health system response to pathogens such as H1N1, Zika, Lassa fever, Marburg virus disease, and COVID-19 at the state, national, and global levels, including medical countermeasure evaluation, diagnostic positioning, infection control policy development, and healthcare worker training. Dr. Bhadelia serves on state, national, and interagency groups focused on biodefense priority setting, development of clinical care guidelines, and medical countermeasures research. She has served as a subject matter expert to the US Centers for Disease Control and Prevention, Department of Defense (DoD), and World Bank.

Dr. Bhadelia has experience with direct patient care, outbreak response, and medical countermeasures research during multiple Ebola virus disease outbreaks in West and East Africa. During the West African Ebola epidemic, she served as a clinician in several Ebola treatment units, working with the World Health Organization and Partners in Health. She currently serves as medical lead of a DoD-funded viral hemorrhagic fever research group in Uganda, entitled Joint Mobile Emerging Disease Intervention Clinical Capability (JMEDICC) program. Dr. Bhadelia codirects the National Institutes of Health’s Fogarty International Center–funded research training program in Liberia, entitled Boston University and University of Liberia Emerging and Epidemic Virus Research (BULEEVR). Her research focuses on global health security, as well as identification of safe and effective clinical interventions and infection control measures related to viral hemorrhagic fevers and other emerging infectious diseases.

Aside from her clinical training in infectious diseases, she has a master’s degree in international affairs from the Fletcher School of Law and Diplomacy and a background in health and human security with a focus on the impact of pandemics on macro level health indicators and community security. Dr. Bhadelia is also an Adjunct Associate Professor at the Institute of Human Security at the Tufts Fletcher School of Law and Diplomacy, where she teaches a course on human security and emerging infectious diseases.

Other Positions

  • Faculty, National Emerging Infectious Disease Lab, Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University

Education

  • Tufts University School of Medicine, MD
  • Tufts University, BS

Classes Taught

  • EP 755
  • EP800
  • PH825,

Publications

  • Published on 11/25/2021

    Alum S, Asiimwe M, Kanyomozi G, Nalikka J, Okwaro P, Migisha I, Muhindo B, Wailagala A, Okello S, Blair P, Waitt P, Bhadelia N, Ayebare R, Kwiecien A, Saunders D, Lamorde M, Kibuuka H, Clark D. Optimizing Highly Infectious Disease Isolation Unit Management: Experiences From the Infectious Diseases Isolation and Research Unit, Fort Portal, Uganda. Disaster Med Public Health Prep. 2021 Nov 25; 1-5. PMID: 34819204.

    Read at: PubMed
  • Published on 11/2/2021

    Ragan EJ, McCallum C, Marathe J, Cole M, Hofman M, Henderson AJ, Flack T, Miller NS, Burks EJ, Zhao GQ, Denis R, Lin NH, Jacobson KR, Andry CD, Pelton SI, Duffy ER, Bhadelia N. Pandemic Response Requires Research Samples: A U.S. Safety-Net Hospital's Experience and Call for National Action. Ann Intern Med. 2021 12; 174(12):1727-1732. PMID: 34724402.

    Read at: PubMed
  • Published on 9/1/2021

    Bhatt AS, Adler ED, Albert NM, Anyanwu A, Bhadelia N, Cooper LT, Correa A, Defilippis EM, Joyce E, Sauer AJ, Solomon SD, Vardeny O, Yancy C, Lala A. Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America. J Card Fail. 2022 01; 28(1):93-112. PMID: 34481067.

    Read at: PubMed
  • Published on 8/22/2021

    Gray KL, Walker NF, Martineau F, Bhadelia N, Harmon-Gray WM, Skrip LA, DeMarco J, Konwloh P, Dunbar N. Interruption of tuberculosis detection and care during the Ebola virus disease epidemic (2014-2015) in Liberia: time-series analyses for 2013-2017. Int J Infect Dis. 2021 Nov; 112:13-20. PMID: 34433096.

    Read at: PubMed
  • Published on 7/14/2021

    Asundi A, O'Leary C, Bhadelia N. Global COVID-19 vaccine inequity: The scope, the impact, and the challenges. Cell Host Microbe. 2021 07 14; 29(7):1036-1039. PMID: 34265241.

    Read at: PubMed
  • Published on 4/9/2021

    Yuen RR, Steiner D, Pihl RMF, Chavez E, Olson A, Smith EL, Baird LA, Korkmaz F, Urick P, Sagar M, Berrigan JL, Gummuluru S, Corley RB, Quillen K, Belkina AC, Mostoslavsky G, Rifkin IR, Kataria Y, Cappione AJ, Gao W, Lin NH, Bhadelia N, Snyder-Cappione JE. Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 via Multi-Parameter Detection. Front Immunol. 2021; 12:614676. PMID: 33897682.

    Read at: PubMed
  • Published on 4/1/2021

    Anand P, Zhou L, Bhadelia N, Hamer DH, Greer DM, Cervantes-Arslanian AM. Neurologic Findings Among Inpatients With COVID-19 at a Safety-net US Hospital. Neurol Clin Pract. 2021 Apr; 11(2):e83-e91. PMID: 33842075.

    Read at: PubMed
  • Published on 2/27/2021

    Rashid A, Sy KTL, Cabrejas JM, Nichols BE, Bhadelia N, Murray EJ. A clinician's primer on epidemiology for COVID-19. Med (N Y). 2021 Apr 09; 2(4):384-394. PMID: 33681831.

    Read at: PubMed
  • Published on 2/15/2021

    DiLorenzo MA, Baker CA, Herstein JJ, Evans L, Lowe JJ, Gibbs SG, Bhadelia N. Institutional policies and readiness in management of critical illness among patients with viral hemorrhagic fever. Infect Control Hosp Epidemiol. 2021 11; 42(11):1307-1312. PMID: 33583468.

    Read at: PubMed
  • Published on 1/20/2021

    Strampe J, Asogun DA, Speranza E, Pahlmann M, Soucy A, Bockholt S, Pallasch E, Becker-Ziaja B, Duraffour S, Bhadelia N, Ighodalo Y, Oyakhilome J, Omomoh EO, Olokor T, Adomeh DI, Ikponwonsa O, Aire C, Tobin E, Akpede N, Okokhere PO, Okogbenin SA, Akpede GO, Muñoz-Fontela C, Ogbaini-Emovon E, Günther S, Connor JH, Oestereich L. Factors associated with progression to death in patients with Lassa fever in Nigeria: an observational study. Lancet Infect Dis. 2021 06; 21(6):876-886. PMID: 33484646.

    Read at: PubMed

View 33 more publications: View full profile at BUMC

View all profiles